Michael Siekman counsels clients of all sizes in the biotechnology and pharmaceutical industries on a range of intellectual property matters, including patent prosecution and portfolio strategy, licensing, post grant proceedings, and litigation. His over 25 years of experience has included developing patent portfolios for several pioneering biotechnologies, most recently in the area of synthetic biology, and leveraging those portfolios to meet his clients’ business goals.
Michael has successfully run and argued several ex parte and inter partes cases before the Patent Trial and Appeal Board (PTAB), and he has coordinated several successful oppositions before the European Patent Office. He is also regularly involved in litigations for clients he represents—though a good part of his practice involves trying to avoid such contested matters, keeping in mind his clients’ business goals at all times.
Michael’s extensive transactional experience includes settlement agreements from the dozens of contested cases he has handled before the PTAB since the mid1990s; strategic collaboration agreements between clients and partners; IPrelated aspects of mergers, acquisitions, IPOs and other financings; and large licensing programs run by clients for portfolios licensed to many companies.
Michael’s prosecution advice is heavily informed by his experience with HatchWaxman litigation for generic drugs and postgrant matters for biosimilars, and he advises clients about these issues regularly. He has handled numerous patent term extensions, as well as supplementary protection certificates, since the mid-90s, and he has written on this topic.
As a parent of a child with Type 1 diabetes, Michael particularly enjoys representing biotechnology and medical device companies in that field.
Michael served as CoChair of the firm’s Biotechnology Group from 2009-2016 and served as Chair of the Practice Group Leaders from 2015-2019.
"Michael defines what it means to get quality work. It is timely and at a reasonable cost."
"Michael is really willing to do what is right for us and not dictate to us how we should do something."
Michael received a National Science Foundation Award in college and served as Articles Editor for the Boston University Journal of Science & Technology Law in law school.
He has also been repeatedly named since 2011 to the Massachusetts Super Lawyers list for his work in the field of intellectual property law.
A former collegiate soccer player, Michael coached his children’s teams for over 20 seasons.